You know why you are having higher than average wait times #unitedhealthcare? It's because you are making me do a peer-to-peer for intrathecal chemotherapy.
Excited to present results of our investigator-initiated trial, which administered LintuzumabAc225 after CLAG-M salvage for RR-AML at #ASH22. At a moderate volume center, it was a labor of love, taking 4 years to fully enroll, but worth it due to some noteworthy responses. 1/
Going forward, no medical conferences should be done in states that deny health care for women.
The next @ASH_hematology meeting is in Louisiana and the next AACR meeting in Florida.
Milwaukee is a great place to live and @MCW is a great place to work. Come join me as @MCWCancerCenter is hiring a GI medical oncologist. DM me with questions!
@sghmd@US_FDA Is this actually a fifth dose for many of our heme malignancy/bmt patients then? 3 shot primary series then booster 1 and now booster 2? I’m finding it a bit easier to just count them rather than name them tbh.